Ischemic heart disease Board decisions

The Board denied service connection for coronary artery disease and remanded the claims for peripheral arterial disease, left leg; peripheral arterial disease, right leg; and peripheral neuropathy, both left and right legs.

The Board granted service connection for congestive heart failure, cardiomyopathy, and hypertension based on herbicide exposure at Fort McClellan. High cholesterol was denied.

The Board remands the issue of entitlement to service connection for a heart disability, as there is sufficient evidence to warrant providing the Veteran a VA examination and/or opinion regarding whether a current heart disability is present.

The Board granted service connection for coronary artery disease (CAD) due to herbicide exposure during the Veteran's active duty. The claim for acne was remanded for further development.

The Board grants the Veteran's appeal for an earlier effective date of January 25, 2022, for the award of service connection for heart disabilities based on direct service connection.

The appeal was dismissed as the Veteran withdrew all claims, including the instant appeal, on January 27, 2025.

The Board granted a 100 percent evaluation for the service-connected heart disability from July 1, 2020 to March 3, 2023 and denied evaluations in excess of 70 percent for PTSD, 10 percent for tinnitus, and no compensable rating for bilateral hearing loss. The claim for TDIU based solely on the service-connected heart disability was dismissed.

The Board remands the claims for further development due to a pre-decisional duty to assist error.

The Board granted an effective date of July 17, 2023, for the award of service connection for coronary artery disease based on presumptive service connection due to exposure to herbicide agents.

The Veteran's claim for benefits under the Home Improvement and Structural Alterations (HISA) program to remodel the entrance of his home, including railings on both sides and replacement of carpet, was granted.

The Board granted service connection for coronary artery disease, diabetes mellitus, hypertension, diabetic nephropathy, and lower extremity diabetic peripheral neuropathy as secondary to the service-connected diabetes mellitus. The right and left upper extremity peripheral neuropathies were denied.

The Board remands the issues of a higher rating for CAD with atherosclerosis and an earlier effective date for PVD to obtain additional evidence.

The Board granted service connection for lacunar infarcts/stroke and major vascular neurocognitive disorder as secondary to the Veteran's service-connected hypertension, and an earlier effective date of June 26, 2021 for arteriosclerotic heart disease (coronary artery disease). The initial rating for hypertension was denied.

The Board granted service connection for cardiomyopathy and remanded the claims for heart disorder, to include transient ischemic attack, chronic systolic heart failure, and heart disease. The claim for hypertension was denied.

The Board denied the claims for service connection for ischemic heart disease, an increased rating for isolated systolic hypertension, and remanded the claims for increased ratings for shoulder arthritis and service connection for squamous skin cancer.

The Board granted the restoration of a 60 percent rating for coronary artery disease and earlier effective dates for TDIU and DEA benefits.

The Board denied service connection for a low back condition and bradycardia, finding that the evidence did not support a link between these conditions and the Veteran's period of active service.

The Board denied increased ratings for the Veteran's service-connected nephropathy with hypertension, DM II, left and right lower extremity peripheral neuropathies, and CAD. However, a total disability rating based on individual unemployability due to service-connected disabilities (TDIU) was granted.

The Board remands the claim for a new medical opinion to address whether the Veteran's asbestos exposure contributed to his death.

The Board denied service connection for an ear disability but remanded claims for a heart disability and eczema due to potential exposure to toxins.